Brief: Jenscare Scientific Expects Revenue Of RMB90-92 Million For 2025
26/01/2026 10:23
Jan 26 (Reuters) - Jenscare Scientific Co Ltd 9877.HK: EXPECTS REVENUE OF RMB90-92 MILLION FOR 2025 EXPECTED RESULT DUE TO SOLID REVENUE FROM KEN-VALVE, OTHERS IN FY Further company coverage: 9877.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jenscare Scientific Co
See all newsBrief: Jenscare Scientific Says Ken-Valve Transcatheter Aortic Valve Replacement System Receives HK Approval
Brief: Jenscare Scientific Posts FY Revenue Of RMB90.6 Million
Brief: Jenscare Scientific Appoints Li Yuanyuan As CFO
Brief: Jenscare Scientific Receives NZ Approval For Ken-Valve And Lux-Valve Plus
Brief: Jenscare Scientific Says Lux-Valve Plus Receives FDA IDE Approval For Pivotal Trial